Inamed talks at the German Pharm-Tox Summit 2017

Joining one of Germany's most recognized pharmacology congresses, Inamed was honored to talk at the Germany Pharm Tox Summit, at the Workshop AGAH on Wednesday 08 March 2017.

The main title of the Workshop was "Exploratory drug development – How to gather crucial information required for clinical success?"
Inamed's CMO Dr. Wolfgang Timmer gave some insights on "Early-phase trials in patients or in healthy subjects?" as part of the Session “Modern trial designs in early clinical development”
With this workshop we brought some detailed insight to early phase trial design to young scientists working in basic pharmacological research and other colleagues involved in biomedical research who would like to know more about early phase clinical development.